You are here

  • Home
  • Archive
  • Volume 74, Issue 9
  • A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study

 

Online download statistics by month:

Online download statistics by month: April 2014 to March 2024

AbstractFullPdf
Apr 201458451154
May 20143098281
Jun 20141093135
Jul 20142612432
Aug 20141373426
Sep 20141462836
Oct 2014983231
Nov 2014752024
Dec 2014651013
Jan 2015652118
Feb 2015701421
Mar 2015712216
Apr 2015531916
May 2015572321
Jun 2015521410
Jul 2015591320
Aug 2015168598142
Sep 20158994381
Oct 20152652036
Nov 20152152833
Dec 20151822629
Jan 20161802837
Feb 20161192320
Mar 2016911519
Apr 20161153233
May 20161061821
Jun 2016943831
Jul 2016901115
Aug 20161112522
Sep 20161613039
Oct 20161432431
Nov 2016972927
Dec 2016921354
Jan 20171011113
Feb 201711299
Mar 20171191913
Apr 20171042420
May 2017841411
Jun 201712299
Jul 2017186910
Aug 2017266811
Sep 20171861516
Oct 20172151310
Nov 20172261213
Dec 20171751111
Jan 20181761413
Feb 2018147611
Mar 201816293
Apr 20181862212
May 201829595
Jun 201812887
Jul 201811977
Aug 2018116162
Sep 201810572
Oct 201811368
Nov 20182482311
Dec 2018120165
Jan 2019711012
Feb 201910142
Mar 201912377
Apr 20198288
May 20197687
Jun 20193455
Jul 20196485
Aug 20197154
Sep 20194178
Oct 20196334
Nov 20197354
Dec 201910299
Jan 202062116
Feb 2020115157
Mar 202013967
Apr 202011773
May 202088117
Jun 20207976
Jul 202010596
Aug 20205778
Sep 202099124
Oct 2020133814
Nov 20205652
Dec 20204752
Jan 20216912
Feb 20215474
Mar 20215667
Apr 20216376
May 202146137
Jun 2021991
Jul 2021964
Aug 2021663
Sep 202111912
Oct 20215932
Nov 202114042
Dec 202182163
Jan 2022110125
Feb 20226875
Mar 20228541
Apr 202210441
May 202211441
Jun 202283131
Jul 20227251
Aug 2022122115
Sep 2022146178
Oct 2022128117
Nov 20222331813
Dec 2022101114
Jan 20236793
Feb 2023148103
Mar 202311430
Apr 2023115138
May 2023137129
Jun 20234652
Jul 20235372
Aug 202311633
Sep 202319730
Oct 2023439112
Nov 202363991
Dec 2023363204
Jan 2024142209
Feb 2024136118
Mar 202412194
Total1746817671766